COVID-19 Impact on Global Personalized Cancer Medicine Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Monoclonal Antibodies
  • 1.4.3 Personalized Cancer Vaccines
  • 1.4.4 Other
• 1.5 Market by Application
  • 1.5.1 Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2026
  • 1.5.2 Breast Cancer
  • 1.5.3 Lung Cancer
  • 1.5.4 Chronic Myeloid Leukaemia
  • 1.5.5 Bowel Cancer
  • 1.5.6 Other Cancer
• 1.6 Coronavirus Disease 2019 (Covid-19): Personalized Cancer Medicine Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Personalized Cancer Medicine Industry
    • 1.6.1.1 Personalized Cancer Medicine Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Personalized Cancer Medicine Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Personalized Cancer Medicine Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Personalized Cancer Medicine Market Perspective (2015-2026)
• 2.2 Personalized Cancer Medicine Growth Trends by Regions
  • 2.2.1 Personalized Cancer Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Personalized Cancer Medicine Historic Market Share by Regions (2015-2020)
  • 2.2.3 Personalized Cancer Medicine Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Personalized Cancer Medicine Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Personalized Cancer Medicine Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Personalized Cancer Medicine Players by Market Size
  • 3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2015-2020)
  • 3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Personalized Cancer Medicine Market Concentration Ratio
  • 3.2.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2019
• 3.3 Personalized Cancer Medicine Key Players Head office and Area Served
• 3.4 Key Players Personalized Cancer Medicine Product Solution and Service
• 3.5 Date of Enter into Personalized Cancer Medicine Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2015-2020)
• 4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2021-2026)

5 Personalized Cancer Medicine Breakdown Data by Application (2015-2026)

• 5.1 Global Personalized Cancer Medicine Market Size by Application (2015-2020)
• 5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Personalized Cancer Medicine Market Size (2015-2020)
• 6.2 Personalized Cancer Medicine Key Players in North America (2019-2020)
• 6.3 North America Personalized Cancer Medicine Market Size by Type (2015-2020)
• 6.4 North America Personalized Cancer Medicine Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Personalized Cancer Medicine Market Size (2015-2020)
• 7.2 Personalized Cancer Medicine Key Players in Europe (2019-2020)
• 7.3 Europe Personalized Cancer Medicine Market Size by Type (2015-2020)
• 7.4 Europe Personalized Cancer Medicine Market Size by Application (2015-2020)

8 China

• 8.1 China Personalized Cancer Medicine Market Size (2015-2020)
• 8.2 Personalized Cancer Medicine Key Players in China (2019-2020)
• 8.3 China Personalized Cancer Medicine Market Size by Type (2015-2020)
• 8.4 China Personalized Cancer Medicine Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Personalized Cancer Medicine Market Size (2015-2020)
• 9.2 Personalized Cancer Medicine Key Players in Japan (2019-2020)
• 9.3 Japan Personalized Cancer Medicine Market Size by Type (2015-2020)
• 9.4 Japan Personalized Cancer Medicine Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Personalized Cancer Medicine Market Size (2015-2020)
• 10.2 Personalized Cancer Medicine Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Personalized Cancer Medicine Market Size by Type (2015-2020)
• 10.4 Southeast Asia Personalized Cancer Medicine Market Size by Application (2015-2020)

11 India

• 11.1 India Personalized Cancer Medicine Market Size (2015-2020)
• 11.2 Personalized Cancer Medicine Key Players in India (2019-2020)
• 11.3 India Personalized Cancer Medicine Market Size by Type (2015-2020)
• 11.4 India Personalized Cancer Medicine Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Personalized Cancer Medicine Market Size (2015-2020)
• 12.2 Personalized Cancer Medicine Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Personalized Cancer Medicine Market Size by Type (2015-2020)
• 12.4 Central & South America Personalized Cancer Medicine Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview and Its Total Revenue
  • 13.1.3 Abbott Personalized Cancer Medicine Introduction
  • 13.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview and Its Total Revenue
  • 13.2.3 Merck Personalized Cancer Medicine Introduction
  • 13.2.4 Merck Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 Novartis
  • 13.3.1 Novartis Company Details
  • 13.3.2 Novartis Business Overview and Its Total Revenue
  • 13.3.3 Novartis Personalized Cancer Medicine Introduction
  • 13.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.3.5 Novartis Recent Development
• 13.4 Amgen
  • 13.4.1 Amgen Company Details
  • 13.4.2 Amgen Business Overview and Its Total Revenue
  • 13.4.3 Amgen Personalized Cancer Medicine Introduction
  • 13.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.4.5 Amgen Recent Development
• 13.5 Celgene
  • 13.5.1 Celgene Company Details
  • 13.5.2 Celgene Business Overview and Its Total Revenue
  • 13.5.3 Celgene Personalized Cancer Medicine Introduction
  • 13.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.5.5 Celgene Recent Development
• 13.6 Bayer
  • 13.6.1 Bayer Company Details
  • 13.6.2 Bayer Business Overview and Its Total Revenue
  • 13.6.3 Bayer Personalized Cancer Medicine Introduction
  • 13.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.6.5 Bayer Recent Development
• 13.7 Roche
  • 13.7.1 Roche Company Details
  • 13.7.2 Roche Business Overview and Its Total Revenue
  • 13.7.3 Roche Personalized Cancer Medicine Introduction
  • 13.7.4 Roche Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.7.5 Roche Recent Development
• 13.8 Astellas
  • 13.8.1 Astellas Company Details
  • 13.8.2 Astellas Business Overview and Its Total Revenue
  • 13.8.3 Astellas Personalized Cancer Medicine Introduction
  • 13.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.8.5 Astellas Recent Development
• 13.9 Astrazeneca
  • 13.9.1 Astrazeneca Company Details
  • 13.9.2 Astrazeneca Business Overview and Its Total Revenue
  • 13.9.3 Astrazeneca Personalized Cancer Medicine Introduction
  • 13.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.9.5 Astrazeneca Recent Development
• 13.10 Johnson & Johnson
  • 13.10.1 Johnson & Johnson Company Details
  • 13.10.2 Johnson & Johnson Business Overview and Its Total Revenue
  • 13.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
  • 13.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 13.10.5 Johnson & Johnson Recent Development
• 13.11 Agilent
  • 10.11.1 Agilent Company Details
  • 10.11.2 Agilent Business Overview and Its Total Revenue
  • 10.11.3 Agilent Personalized Cancer Medicine Introduction
  • 10.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 10.11.5 Agilent Recent Development
• 13.12 Takeda
  • 10.12.1 Takeda Company Details
  • 10.12.2 Takeda Business Overview and Its Total Revenue
  • 10.12.3 Takeda Personalized Cancer Medicine Introduction
  • 10.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2015-2020)
  • 10.12.5 Takeda Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer